Serotonin transporter function in vivo: Assessment by chronoamperometry

Annals of the New York Academy of Sciences

Volumn 861, Issue , 1998, Pages 217-229

  Frazer, A ^b   Daws, L C ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; AUTORECEPTOR; CITALOPRAM; CYANOPINDOLOL; DESIPRAMINE; FLUVOXAMINE; OXIDOPAMINE; PROTRIPTYLINE; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

AMPEROMETRY; CONFERENCE PAPER; DENTATE GYRUS; HIPPOCAMPUS; NONHUMAN; POTENTIOMETRY; SEROTONIN METABOLISM; SIGNAL TRANSDUCTION;

EID: 0032418723     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10193.x     Document Type: Conference Paper

References (48)

1. 1. SHADER, R. I. & D. J. GREENBLATT. 1995. The pharmacology of acute anxiety: A miniupdate. In Psychopharmacology: The Fourth Generation of Progress. F. E. Bloom & D. J. Kupfer, Eds.: 1341-1348. Raven Press, Ltd. New York.
2. 2. FRAZER, A. 1997. Antidepressants. J. Clin. Psychiatry 58(suppl 6): 9-25.
3. 3. BOROWSKY, B. & B. J. HOFFMAN. 1995. Neurotransmitter transporters: Molecular biology, function and regulation. Int. Rev. Neurobiol. 38: 139-199.
4. 4. QIAN, Y. et al. 1997. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17: 45-57.
5. 5. QIAN, Y. et al. 1995. Phosphorylation of serotonin transporter domains and the role of phosphorylation in acute transporter regulation. Soc. Neurosci. Abstr. 21: 865.
6. 6. KAWAGOE, K. T., J. B. ZIMMERMAN & R. M. WIGHTMAN. 1993. Principles of voltammetry and microelectrode surface states. J. Neurosci. Methods 48: 225-240.
7. 7. GERHARDT, G. A. et al. 1984. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290: 390-394.
8. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269: 1268-1279.
9. 9. CASS, W. A. et al. 1993. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: Comparison with dorsal striatum and nucleus accumbens. J. Neurochem. 6: 2269-2278.
10. 10. CASS, W. A. & G. A. GERHARDT. 1995. Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: Role of metabolism and effects of locally applied uptake inhibitors. J. Neurochem. 65: 201-207.
11. 11. JONES, S. R. et al. 1995. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J. Neurochem. 64: 2581-2589.
12. 12. MARSDEN, C. A. et al. 1979. Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res. 171: 85-99.
13. 13. TAGUCHI, K. & Y. SUZUKI. 1991. Effects of morphine on the electrochemical signal modified by noxious stimuli in the nucleus raphe magnus of anesthetized rats. Neuropharmacology 30: 1225-1231.
14. 14. PUIG, S., J. P. RIVOT & J. M. BESSON. 1993. Effects of tianeptine on 5-hydroxyindoles and on the morphine-induced increase in 5-HT metabolism at the medullary dorsal horn level as measured by in vivo voltammetry in freely moving rats. Brain Res. 600: 219-224.
15. 15. MANFRIDI, A., A. CLAVENNA & M. G. DE SIMONI. 1992. Serotonin uptake inhibition: In vivo effect of sertraline in rats. Neurosci. Lett. 136: 69-72.
16. 16. CLEMENT, H.-W., D. GEMSA & W. WESEMANN. 1992. The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetry. Eur. J. Pharmacol. 217: 43-48.
17. 17. CRESPI, F. 1990. In vivo voltammetry with micro-biosensors for analysis of neurotransmitter release and metabolism. J. Neurosci. Methods 34: 53-65.
18. 18. KRUK, Z. & J. J. O'CONNOR. 1995. Fast electrochemical studies in isolated tissues. Trends Pharmacol. Sci. 16: 145-149.
19. 19. LUTHMAN, J. et al. 1997. In vivo electrochemical measurements of serotonin clearance in rat striatum: Effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors. J. Neural Transm. 104: 379-397.
20. 20. STAMFORD, J. A., Z. L. KRUK & J. MILLAR. 1991. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: In vivo voltammetric data. Br. J. Pharmacol. 102: 45-50.
21. 21. JACKSON, B. P. & R. M. WIGHTMAN. 1995. Dynamics of 5-hydroxytryptamine released from dopamine neurons in the caudate putamen of the rat. Brain Res. 674: 163-166.
22. 22. GÖTHERT, M. & E. SCHLICKER. 1997. Regulation of 5-HT release in the CNS by presynaptic 5-HT autoreceptors and by 5-HT heteroreceptors. In Handbook of Experimental Pharmacology, vol. 129: Serotoninergic Neurons & 5-HT Receptors in the CNS. H. G. BAUMGARTEN & M. GÖTHERT, Eds.: 307-350. Springer-Verlag. Berlin Heidelberg, Germany.
23. 3H-monoamines from field stimulated rat brain slices. Acta Physiol. Scand. 371 (Suppl.): 35-44.
24. 24. LANGER, S. Z. & C. MORET. 1982. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreeeptors in the rat hypothalamus. J. Pharmacol. Exp. Ther. 222: 220-226.
25. 25. FEUERSTEIN, T. J., A. LUPP, & G. HERTTING. 1987. Quantitative evaluation of the autoinhibitory feedback of release of 5-HT in the caudate nucleus of the rabbit where an endogenous tone on alpha 2-adrenoceptors does not exist. Neuropharmacology 26: 1071-1080.
26. 26. BONANNO, G. & M. RAITERI. 1987. Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes. Naunyn-Schmiedeberg's Arch. Pharmacol. 335: 219-225.
27. 27. LIMBERGER, N., K. STARKE & E. A. SINGER. 1990. Serotonin uptake blockers influence serotonin autoreceptors by increasing the biophase concentration of serotonin and not through a quot;molecular link". Naunyn-Schmiedeberg's Arch. Pharmacol. 342: 363-370.
28. 28. MORET, C. & M. BRILEY. 1990. Modulation by drugs of the release of total tritium and 3-H-5-HT from rat hypothalamic slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 341: 398-403.
29. 29. GALZIN, A. M. et al. 1985. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreeeptors in the rat hypothalamus. J. Pharmacol. Exp. Ther. 235: 200-211.
30. 2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176: 259-263.
31. 31. PARSONS, L. H., C. A. SCHAD, & J. B. JUSTICE. 1993. Co-administration of the D2 agonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J. Neurochem. 60: 376-379.
32. 32. MEIERGERD, S. M., T. A. PATTERSON & J. O. SCHENK. 1993. D2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61: 764-767.
33. 33. PAXINOS, G. & C. WATSON. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press. New York.
34. 34. DAWS, L. C et al. 1997. In vivo chronoamperometric measurements of extracellular serotonin clearance in the rat dentate gyrus. J. Neurosci. Methods 78: 139-150.
35. 35. SWANSON, L. W., C. KÖHLER & A. BJÖRKLUND. 1987. The septohippocamal system, chapter II. In Handbook of Chemical Neuroanatomy, vol 5: Integrated Systems of the CNS, Part I. A. Björklund, T. Hökfelt & L. W. Swanson, Eds.: 125-277. Elsevier Science Publishers B.V.
36. 36. BRUNSWICK, D. J. et al. 1992. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse 11: 287-293.
37. 37. LICHTENSTEIGER, W., U. MUTZNER & H. LANGEMANN. 1967. Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines. J. Neurochem. 14: 489-497.
38. 38. SHASKAN, E. G. & S. H. SNYDER. 1970. Kinetics of serotonin accumulation into slices from rat brain: Relationship to catecholamine uptake. J. Pharmacol. Exp. Ther. 17: 404-418.
39. 39. KUHAR, M. J., R. H. ROTH & G. K. AGHAJANIAN. 1972. Synaptosomes from forebrains of rats with midbrain raphe lesions: Selective reduction of serotonin uptake. J. Pharmacol. Exp. Ther. 181: 36-45.
40. 40. CLEMENTS, J. D. 1996. Transmitter timecourse in the synaptic cleft: Its role in central synaptic function. Trends Neurosci. 19: 163-171.
41. 41. CHEN, N.-H. & M. E. A. REITH. 1994. Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: A microdialysis study on monoamine interrelationships. J. Neurochem. 63: 1701-1713.
42. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 274: 866-876.
43. 43. BEL, N. & F. ARTIGAS. 1992. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study. Eur. J. Pharmacol. 229: 101-103.
44. 44. LI, M.-Y. et al. 1996. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monamine uptake blockers. J. Neurochem. 66: 559-568.
45. 45. MORET, C. & M. MARIEN. 1997. Effects of venlafaxine on extracellular levels of 5-HT and noradrenaline in guinea pig hypothalamus. Soc. Neurosci. Abstr. 23: 1225.
46. 46. HOYER, D. et al. 1994. International union of pharmacology classification of receptors for 5-Hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203.
47. 47. ROUSSELLE, J.-C. et al. 1996. Isolation and characterization of an endogenous peptide from rat brain interacting specifically with the serotonergic 1B receptor subtypes. J. Biol. Chem. 271: 726-735.
48. 48. MASSOT, O. et al. 1996. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine 1B/1D receptors. Mol. Pharmacol. 50: 752-762.